MIRM · ISSUER CIK 1759425
Mirum Pharmaceuticals, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 3 Mirum Pharmaceuticals, Inc. insiders reported $0.00 of open-market purchases and $10.8M of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 5 of 7 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$10.8MInsider selling
−$10.8MNet open-market
Oct 19, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 202616:10 | Oct 16, 2026 | MIRM | SVP, GLOBAL CONTROLLER | M · Exercise | $19.24 | +16,112 | 16,728 | +2616% | $310K | ||
| Oct 6, 202620:38 | Oct 6, 2026 | MIRM | CHIEF EXECUTIVE OFFICER, Director | M · Exercise | $17.31 | +12,197 | 206,637 | +6% | $211K | ||
| Sep 15, 202616:10 | Sep 14, 2026 | MIRM | CHIEF FINANCIAL OFFICER | S · Sell | $98.37 | −9,943 | 44,745 | -18% | −$978K | ||
| Sep 15, 202616:10 | Sep 11, 2026 | MIRM | CHIEF FINANCIAL OFFICER | M · Exercise | — | +18,333 | 54,688 | +50% | — | ||
| Sep 3, 202618:54 | Sep 2, 2026 | MIRM | SVP, GLOBAL CONTROLLER | S · Sell10b5-1 | $100.00 | −658 | 616 | -52% | −$66K | ||
| Sep 3, 202618:52 | Sep 1, 2026 | MIRM | CHIEF EXECUTIVE OFFICER, Director | S · Sell10b5-1 | $98.68 | −30,000 | 194,440 | -13% | −$3.0M | ||
| Sep 3, 202618:52 | Sep 1, 2026 | MIRM | CHIEF EXECUTIVE OFFICER, Director | M · Exercise10b5-1 | $2.94 | +30,000 | 224,440 | +15% | $88K | ||
| Aug 19, 202618:19 | Aug 18, 2026 | MIRM | SVP, GLOBAL CONTROLLER | S · Sell | $100.00 | −40,000 | 1,274 | -97% | −$4.0M | ||
| Aug 19, 202618:19 | Aug 18, 2026 | MIRM | SVP, GLOBAL CONTROLLER | M · Exercise | $6.27 | +40,000 | 41,274 | +3140% | $251K | ||
| Aug 12, 202617:14 | Aug 11, 2026 | MIRM | CHIEF FINANCIAL OFFICER | S · Sell10b5-1 | $99.90 | −6,001 | 36,355 | -14% | −$600K | ||
| Aug 11, 202617:41 | Aug 10, 2026 | MIRM | CHIEF EXECUTIVE OFFICER, Director | S · Sell10b5-1 | $98.92 | −20,000 | 194,309 | -9% | −$2.0M | ||
| Aug 11, 202617:41 | Aug 10, 2026 | MIRM | CHIEF EXECUTIVE OFFICER, Director | M · Exercise10b5-1 | $2.94 | +20,000 | 214,309 | +10% | $59K | ||
| Aug 5, 202616:26 | Aug 3, 2026 | MIRM | SVP, GLOBAL CONTROLLER | S · Sell10b5-1 | $105.29 | −1,840 | 1,274 | -59% | −$194K |